In 2018, after nearly two decades working in Big Pharma, chemist Tim Cernak was ready to put his skills to a new use. For Merck, he’d developed precision therapies for cancer, HIV, and diabetes that...
> Intelligence Brief
Get the top AI and tech stories delivered weekly. Curated summaries, no spam, unsubscribe anytime.
No spam. Unsubscribe anytime.